CBX8
| Official symbol: | CBX8 |
| Full name: | chromobox 8 |
| Location: | 17q25.3 |
| Also known as: | PC3, HPC3, RC1 |
| Entrez ID: | 57332 |
| Ensembl ID: | ENSG00000141570 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 1.27 (Driver) | | Gscore (Del): | 0.00 |
|
|
| Recurrently amplified in 5 cancer type(s) | |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | NA |
|
|
|
| |
|
|
|
| Functional class: | Epigenetic |
| JensenLab PubMed score: | 183.43 (Percentile rank: 80.75%) |
| PubTator score: | 1111.57 (Percentile rank: 96.86%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
